Ye et al. demonstrated that both the expression of neutrophil-derived lipocalin 2 (LCN2) and the chemokine CXCR2 were significantly elevated in mouse models and human patients with NAFLD. Here, LCN2 is linked to metabolic dysfunction-associated steatotic liver disease.